[EN] 1-{2-[(DIPHENYL)AMINO]-ETHYL}-PIPERIDINE-4-CARBOXYLIC ACID BENZYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CCR5 AGONISTS FOR THE TREATMENT OF IMMUNE AND INFLAMMATORY DISEASES [FR] DÉRIVÉS DE BENZYLAMIDE DE L'ACIDE 1-{2-[(DIPHÉNYL)AMINO]-ÉTHYL}-PIPÉRIDINE-4-CARBOXYLIQUE ET COMPOSÉS ASSOCIÉS COMME AGONISTES DE CCR5 POUR LE TRAITEMENT DE MALADIES IMMUNES ET INFLAMMATOIRES
[EN] 1-{2-[(DIPHENYL)AMINO]-ETHYL}-PIPERIDINE-4-CARBOXYLIC ACID BENZYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CCR5 AGONISTS FOR THE TREATMENT OF IMMUNE AND INFLAMMATORY DISEASES<br/>[FR] DÉRIVÉS DE BENZYLAMIDE DE L'ACIDE 1-{2-[(DIPHÉNYL)AMINO]-ÉTHYL}-PIPÉRIDINE-4-CARBOXYLIQUE ET COMPOSÉS ASSOCIÉS COMME AGONISTES DE CCR5 POUR LE TRAITEMENT DE MALADIES IMMUNES ET INFLAMMATOIRES
申请人:EUROSCREEN SA
公开号:WO2009010480A1
公开(公告)日:2009-01-22
The present invention relates to pharmaceutically active piperidine derivatives and their use as agonists of CC chemokine receptor activity, more specifically of CCR5 activity. Chemokines are chemotactic cytokines which play an important role in immune and inflammatory responses.